Economic portfolio
Bajaj Finserv Healthcare Fund
BAJAJ Bajaj Finserv Mutual Fund Dec 2024 — Sep 2026 22 months
Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →
Days to sell half: 1.1 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Sep 2026). Quick to unwind on normal volumes. Small-cap comparison →
Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.
How concentrated it has been
22 priced months, Dec 2024 to Sep 2026 · at each month’s NSE closes
Top 10 holdings, share of equity
62.0% now, 50.5% in Sep 2025 · highest 77.2%, lowest 48.7%
Companies held
33 now, 41 in Sep 2025 · largest single holding 10.2% of equity
How long new positions last: of the 21 companies this fund started holding between Jan 2025 and Sep 2025, 67% were still held a year later — it usually keeps what it buys. Across active funds the figure is about 50%, and a fund’s figure has stayed similar from year to year. A description of how the fund is run, not of its results. How this was tested →
How it trades: no clear lean toward recent winners or losers (score +0.08 over 11 months; −1 always buys the biggest fallers, +1 the biggest risers, 0 no pattern). Value and contra funds average −0.10, other active funds about 0. A description of behaviour, not of results. How this was tested →
Sector mix
Share of the equity shown · NSE industry
Funds most like this one
Overlap of disclosed equity · the smaller share of each company both hold, added up
- Mirae Asset Nifty 500 Healthcare ETFMirae Asset · 24 shared61.7%
- ADITYA BIRLA SUN LIFE NIFTY HEALTHCARE ETFAditya Birla Sun Life · 16 shared58.3%
- ICICI Prudential Nifty Healthcare ETFICICI Prudential · 16 shared58.3%
- DSP Nifty Healthcare ETFDSP · 16 shared58.3%
- DSP Nifty Healthcare Index FundDSP · 16 shared58.3%
- Axis NIFTY Healthcare ETFAxis · 16 shared58.3%
- Mirae Asset Healthcare FundMirae Asset · 18 shared57.5%
- EODWHFEdelweiss · 16 shared57.1%
Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.
What changed in Sep 2026
This portfolio’s consecutive disclosures · evidenced adjustments applied
New positions
Complete exits
Largest increases
Largest reductions
Share quantities, not market values or cash flows.
Holdings by value
Sep 2026 · largest 100 · share of the equity shown
| Company | Sector | Size | Share of equity | Value | Shares held | Held since |
|---|---|---|---|---|---|---|
| Divi's Laboratories Limited | Healthcare | Large Cap | 10.21% | 39.52 Cr | 42,533 | by Dec 2024 (22 mo+) |
| Sun Pharmaceutical Industries Limited | Healthcare | Large Cap | 9.38% | 36.30 Cr | 0.02 Cr | by Dec 2024 (22 mo+) |
| Piramal Pharma Limited | Healthcare | Small Cap | 6.65% | 25.75 Cr | 0.12 Cr | by Dec 2024 (22 mo+) |
| Rubicon Research Limited | Healthcare | Small Cap | 6.36% | 24.61 Cr | 0.02 Cr | Oct 2025 (12 mo) |
| Aurobindo Pharma Limited | Healthcare | Mid Cap | 6.31% | 24.43 Cr | 0.01 Cr | Apr 2025 (18 mo) |
| Apollo Hospitals Enterprise Limited | Healthcare | Large Cap | 5.77% | 22.34 Cr | 27,355 | by Dec 2024 (22 mo+) |
| Torrent Pharmaceuticals Limited | Healthcare | Large Cap | 5.00% | 19.36 Cr | 40,333 | Jan 2025 (21 mo) |
| Emcure Pharmaceuticals Limited | Healthcare | Small Cap | 4.22% | 16.33 Cr | 84,054 | by Dec 2024 (22 mo+) |
| Laurus Labs Limited | Healthcare | Mid Cap | 4.09% | 15.84 Cr | 80,000 | Mar 2026 (7 mo) |
| Neuland Laboratories Limited | Healthcare | Small Cap | 3.99% | 15.46 Cr | 7,242 | by Dec 2024 (22 mo+) |
| Max Healthcare Institute Limited | Healthcare | Large Cap | 3.13% | 12.12 Cr | 0.01 Cr | May 2025 (17 mo) |
| Alkem Laboratories Limited | Healthcare | Mid Cap | 3.10% | 12.00 Cr | 23,236 | Sep 2026 (1 mo) |
| Zydus Lifesciences Limited | Healthcare | Mid Cap | 2.69% | 10.41 Cr | 89,621 | May 2026 (5 mo) |
| IPCA Laboratories Limited | Healthcare | Mid Cap | 2.51% | 9.73 Cr | 50,483 | by Dec 2024 (22 mo+) |
| Fortis Healthcare Limited | Healthcare | Mid Cap | 2.39% | 9.25 Cr | 0.01 Cr | May 2025 (17 mo) |
| Zydus Wellness Limited | Fast Moving Consumer Goods | Small Cap | 2.30% | 8.90 Cr | 0.02 Cr | by Dec 2024 (22 mo+) |
| Vijaya Diagnostic Centre Limited | Healthcare | Small Cap | 2.29% | 8.87 Cr | 61,718 | Jan 2025 (21 mo) |
| Senores Pharmaceuticals Limited | Healthcare | Small Cap | 2.18% | 8.45 Cr | 60,946 | Apr 2026 (6 mo) |
| Shaily Engineering Plastics Limited | Consumer Durables | Small Cap | 1.96% | 7.60 Cr | 24,809 | Jan 2025 (21 mo) |
| Dr. Lal Path Labs Ltd. | Healthcare | Small Cap | 1.81% | 7.00 Cr | 35,236 | Jan 2025 (21 mo) |
| GlaxoSmithKline Pharmaceuticals Limited | Healthcare | Mid Cap | 1.70% | 6.59 Cr | 23,792 | by Dec 2024 (22 mo+) |
| Glenmark Pharmaceuticals Limited | Healthcare | Mid Cap | 1.67% | 6.48 Cr | 27,743 | by Dec 2024 (22 mo+) |
| Dr. Reddy's Laboratories Limited | Healthcare | Large Cap | 1.43% | 5.55 Cr | 45,000 | Jul 2026 (3 mo) |
| Cipla Limited | Healthcare | Large Cap | 1.39% | 5.38 Cr | 40,000 | Aug 2026 (2 mo) |
| Sanofi Consumer Healthcare India Limited | Not classified | Small Cap | 1.36% | 5.27 Cr | 13,863 | by Dec 2024 (22 mo+) |
| Biocon Limited | Healthcare | Mid Cap | 1.10% | 4.24 Cr | 0.01 Cr | by Dec 2024 (22 mo+) |
| Navin Fluorine International Limited | Chemicals | Small Cap | 0.98% | 3.80 Cr | 4,610 | Feb 2026 (8 mo) |
| Krishna Institute of Medical Sciences Limited | Healthcare | Small Cap | 0.96% | 3.73 Cr | 50,000 | Feb 2026 (8 mo) |
| Jubilant Pharmova Limited | Healthcare | Small Cap | 0.93% | 3.60 Cr | 34,986 | Jan 2025 (21 mo) |
| Onesource Specialty Pharma Limited | Healthcare | Small Cap | 0.86% | 3.35 Cr | 22,000 | Jul 2026 (3 mo) |
| Medi Assist Healthcare Services Limited | Not classified | Small Cap | 0.79% | 3.04 Cr | 0.01 Cr | Jan 2025 (21 mo) |
| Neogen Chemicals Limited | Chemicals | Small Cap | 0.24% | 0.94 Cr | 3,854 | Aug 2026 (2 mo) |
| Sumitomo Chemical India Limited | Chemicals | Small Cap | 0.22% | 0.87 Cr | 20,000 | Jul 2026 (3 mo) |
Half of its current holdings have been held for 21 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.
Recent position changes
Latest 100 company-month records · evidenced adjustments applied
| Company | Month | Activity | Adjusted change |
|---|---|---|---|
| Turtlemint Fintech Solutions Limited | Sep 2026 | ▼ Complete exit | -0.03 Cr |
| Sun Pharmaceutical Industries Limited | Sep 2026 | ▲ Increasing | +32,000 |
| Laurus Labs Limited | Sep 2026 | ▲ Increasing | +30,000 |
| Piramal Pharma Limited | Sep 2026 | ▼ Reducing | -25,000 |
| Alkem Laboratories Limited | Sep 2026 | ▲ New position | +23,236 |
| Divi's Laboratories Limited | Sep 2026 | ▼ Reducing | -2,694 |
| MTAR Technologies Limited | Sep 2026 | ▼ Complete exit | -1,500 |
| Zydus Lifesciences Limited | Aug 2026 | ▲ Increasing | +45,000 |
| Cipla Limited | Aug 2026 | ▲ New position | +40,000 |
| Navin Fluorine International Limited | Aug 2026 | ▼ Reducing | -5,390 |
| Neogen Chemicals Limited | Aug 2026 | ▲ New position | +3,854 |
| Neuland Laboratories Limited | Aug 2026 | ▼ Reducing | -1,500 |
| Medplus Health Services Limited | Jul 2026 | ▼ Complete exit | -51,652 |
| Sun Pharmaceutical Industries Limited | Jul 2026 | ▲ Increasing | +47,000 |
| Dr. Reddy's Laboratories Limited | Jul 2026 | ▲ New position | +45,000 |
| Eris Lifesciences Limited | Jul 2026 | ▼ Complete exit | -25,000 |
| Onesource Specialty Pharma Limited | Jul 2026 | ▲ New position | +22,000 |
| Sumitomo Chemical India Limited | Jul 2026 | ▲ New position | +20,000 |
| AstraZeneca Pharma India Limited | Jul 2026 | ▼ Complete exit | -3,267 |
| Abbott India Limited | Jul 2026 | ▼ Complete exit | -1,738 |
| Turtlemint Fintech Solutions Limited | Jun 2026 | ▲ New position | +0.03 Cr |
| ICICI Prudential Life Insurance Company Limited | Jun 2026 | ▼ Complete exit | -60,000 |
| Piramal Pharma Limited | Jun 2026 | ▲ Increasing | +19,622 |
| Max Healthcare Institute Limited | Jun 2026 | ▲ Increasing | +3,491 |
| Rubicon Research Limited | Jun 2026 | ▲ Increasing | +2,563 |
| Aurobindo Pharma Limited | Jun 2026 | ▲ Increasing | +2,363 |
| Emcure Pharmaceuticals Limited | Jun 2026 | ▲ Increasing | +2,052 |
| MTAR Technologies Limited | Jun 2026 | ▼ Reducing | -1,000 |
| Torrent Pharmaceuticals Limited | Jun 2026 | ▲ Increasing | +708 |
| Zydus Lifesciences Limited | Jun 2026 | ▼ Reducing | -379 |
| Neuland Laboratories Limited | Jun 2026 | ▲ Increasing | +203 |
| Emami Limited | May 2026 | ▼ Complete exit | -64,782 |
| ICICI Prudential Life Insurance Company Limited | May 2026 | ▲ New position | +60,000 |
| Godrej Consumer Products Limited | May 2026 | ▼ Complete exit | -50,000 |
| Zydus Lifesciences Limited | May 2026 | ▲ New position | +45,000 |
| Sun Pharmaceutical Industries Limited | May 2026 | ▼ Reducing | -40,000 |
| Senores Pharmaceuticals Limited | May 2026 | ▲ Increasing | +30,824 |
| Lupin Limited | May 2026 | ▼ Complete exit | -20,256 |
| Aurobindo Pharma Limited | May 2026 | ▼ Reducing | -9,049 |
| MTAR Technologies Limited | May 2026 | ▲ New position | +2,500 |
| Senores Pharmaceuticals Limited | Apr 2026 | ▲ New position | +30,122 |
| Laurus Labs Limited | Mar 2026 | ▲ New position | +50,000 |
| Alembic Pharmaceuticals Limited | Mar 2026 | ▼ Complete exit | -39,947 |
| TATA CONSUMER PRODUCTS LIMITED | Mar 2026 | ▼ Complete exit | -30,000 |
| Cipla Limited | Mar 2026 | ▼ Complete exit | -23,706 |
| Lupin Limited | Mar 2026 | ▼ Reducing | -16,022 |
| Kwality Wall's (India) Limited | Mar 2026 | ▼ Complete exit | -15,581 |
| Hindustan Unilever Limited | Mar 2026 | ▼ Complete exit | -15,581 |
| Zydus Wellness Limited | Mar 2026 | ▲ Increasing | +10,000 |
| Sun Pharmaceutical Industries Limited | Mar 2026 | ▲ Increasing | +8,590 |
| Neuland Laboratories Limited | Mar 2026 | ▲ Increasing | +200 |
| Piramal Pharma Limited | Feb 2026 | ▲ Increasing | +0.05 Cr |
| ETERNAL LIMITED | Feb 2026 | ▼ Complete exit | -0.02 Cr |
| Max Healthcare Institute Limited | Feb 2026 | ▲ Increasing | +91,875 |
| Biocon Limited | Feb 2026 | ▼ Reducing | -75,000 |
| Cipla Limited | Feb 2026 | ▼ Reducing | -62,721 |
| Krishna Institute of Medical Sciences Limited | Feb 2026 | ▲ New position | +50,000 |
| Rainbow Childrens Medicare Limited | Feb 2026 | ▼ Complete exit | -29,503 |
| Torrent Pharmaceuticals Limited | Feb 2026 | ▲ Increasing | +29,299 |
| Eris Lifesciences Limited | Feb 2026 | ▲ New position | +25,000 |
| Glenmark Pharmaceuticals Limited | Feb 2026 | ▼ Reducing | -16,080 |
| Zydus Wellness Limited | Feb 2026 | ▲ Increasing | +14,887 |
| Pfizer Limited | Feb 2026 | ▼ Complete exit | -13,314 |
| Navin Fluorine International Limited | Feb 2026 | ▲ New position | +10,000 |
| Syngene International Limited | Jan 2026 | ▼ Complete exit | -55,139 |
| Marico Limited | Jan 2026 | ▼ Complete exit | -31,592 |
| Cipla Limited | Jan 2026 | ▼ Reducing | -25,484 |
| Mankind Pharma Limited | Jan 2026 | ▼ Complete exit | -14,526 |
| Zydus Wellness Limited | Jan 2026 | ▲ Increasing | +10,718 |
| Biocon Limited | Dec 2025 | ▼ Reducing | -0.01 Cr |
| ETERNAL LIMITED | Dec 2025 | ▲ Increasing | +0.01 Cr |
| Rubicon Research Limited | Dec 2025 | ▲ Increasing | +21,800 |
| Kwality Wall's (India) Limited | Dec 2025 | ▲ New position | +15,581 |
| Glenmark Pharmaceuticals Limited | Dec 2025 | ▲ Increasing | +8,160 |
| GlaxoSmithKline Pharmaceuticals Limited | Dec 2025 | ▲ Increasing | +2,845 |
| Divi's Laboratories Limited | Dec 2025 | ▲ Increasing | +1,291 |
| Piramal Pharma Limited | Nov 2025 | ▲ Increasing | +0.03 Cr |
| ETERNAL LIMITED | Nov 2025 | ▲ New position | +87,500 |
| Aurobindo Pharma Limited | Nov 2025 | ▲ Increasing | +59,123 |
| Dr. Reddy's Laboratories Limited | Nov 2025 | ▼ Complete exit | -50,243 |
| TATA CONSUMER PRODUCTS LIMITED | Nov 2025 | ▲ New position | +30,000 |
| Cohance Lifesciences Limited | Nov 2025 | ▼ Complete exit | -11,985 |
| Dr. Lal Path Labs Ltd. | Nov 2025 | ▼ Reducing | -10,337 |
| Emami Limited | Nov 2025 | ▲ Increasing | +9,783 |
| Neogen Chemicals Limited | Nov 2025 | ▼ Complete exit | -9,432 |
| Alkem Laboratories Limited | Nov 2025 | ▼ Complete exit | -8,185 |
| Rubicon Research Limited | Oct 2025 | ▲ New position | +0.01 Cr |
| Dr. Reddy's Laboratories Limited | Oct 2025 | ▼ Reducing | -40,192 |
| Nestle India Limited | Oct 2025 | ▼ Complete exit | -13,892 |
| Glenmark Pharmaceuticals Limited | Oct 2025 | ▼ Reducing | -13,298 |
| PB Fintech Limited | Oct 2025 | ▼ Complete exit | -9,836 |
| Fortis Healthcare Limited | Oct 2025 | ▼ Reducing | -7,227 |
| Dr. Lal Path Labs Ltd. | Oct 2025 | ▼ Reducing | -5,506 |
| Cipla Limited | Oct 2025 | ▼ Reducing | -4,899 |
| Pfizer Limited | Oct 2025 | ▼ Reducing | -3,004 |
| Torrent Pharmaceuticals Limited | Oct 2025 | ▼ Reducing | -2,363 |
| Alkem Laboratories Limited | Oct 2025 | ▼ Reducing | -1,370 |
| Syngene International Limited | Sep 2025 | ▼ Reducing | -0.01 Cr |
| Emami Limited | Sep 2025 | ▼ Reducing | -20,346 |
| Biocon Limited | Sep 2025 | ▲ Increasing | +12,000 |
Changes compare consecutive month-end disclosures for this portfolio only.